SCHEMBL9998153

SCHEMBL9998153

CC(=O)OCC(C)=Cc1cccc(Br)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.48
HSD17B3 P37058 1/20 0.45
SLC6A19 Q695T7 1/20 0.43
ALDH1A1 P00352 2/20 0.43
AKR1C3 P42330 1/20 0.42
AKR1C2 P52895 1/20 0.42
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
BACE1 P56817 1/20 0.40
LMNA P02545 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HTT P42858 1/20 0.40
MAPK1 P28482 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998151 1.00 PKM (0.48) PKMHSD17B3SLC6A19ALDH1A1AKR1C3
SCHEMBL9998274 0.84 PKM (0.45) PKMHSD17B3SLC6A19ALDH1A1AKR1C3
SCHEMBL9998455 0.84 PKM (0.45) PKMHSD17B3SLC6A19ALDH1A1AKR1C3
SCHEMBL9997669 0.84 PKM (0.45) PKMHSD17B3SLC6A19ALDH1A1AKR1C3
SCHEMBL9998220 0.83 LMNA (0.44) PKMALDH1A1MEN1KMT2ALMNA
SCHEMBL9998218 0.83 LMNA (0.44) PKMALDH1A1MEN1KMT2ALMNA
SCHEMBL9998170 0.82 PKM (0.43) PKMHSD17B3SLC6A19ALDH1A1AKR1C3
SCHEMBL9998171 0.82 PKM (0.43) PKMHSD17B3SLC6A19ALDH1A1AKR1C3
SCHEMBL9997519 0.82 MAPT (0.51) ALDH1A1AKR1C3AKR1C2MEN1KMT2A
SCHEMBL9997812 0.82 CACNA1B (0.50) PKMALDH1A1AKR1C3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 PKM 1948/4885HSD17B3 454/4885SLC6A19 1360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.